血管舒缩症状-话题@MedSci - 梅斯（MedSci）

#血管舒缩症状#

8篇内容 | 1082人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2221853, encodeId=f5b12221853b1, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a> <a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a> <a href='/topic/show?id=0ae5118191b9' target=_blank style='color:#2F92EE;'>#亚临床动脉粥样硬化性心血管疾病#</a>, objectTitle=JAHA：绝经期血管舒缩症状与亚临床动脉粥样硬化性心血管疾病的关系, objectType=article, longId=840014, objectId=373984001496, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240612/1718183341497_92910.jpg, objectUrl=/article/show_article.do?id=373984001496, replyNumber=0, likeNumber=79, createdTime=2024-08-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=373984001496, moduleTitle=JAHA：绝经期血管舒缩症状与亚临床动脉粥样硬化性心血管疾病的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=373984001496)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2218144, encodeId=15942218144b6, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a> <a href='/topic/show?id=1b7d11e4689d' target=_blank style='color:#2F92EE;'>#elinzanetant#</a>, objectTitle=elinzanetant 新药递交FDA上市申请，用于治疗与绝经相关的中度至重度血管舒缩症状, objectType=article, longId=837020, objectId=36ce83e020ae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240730/1722330274156_8538692.jpg, objectUrl=/article/show_article.do?id=36ce83e020ae, replyNumber=0, likeNumber=51, createdTime=2024-08-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=36ce83e020ae, moduleTitle=elinzanetant 新药递交FDA上市申请，用于治疗与绝经相关的中度至重度血管舒缩症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=36ce83e020ae)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2037427, encodeId=15dc203e42727, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=Fezolinetant治疗中度至重度血管舒缩症状，III期研究未达到主要终点, objectType=article, longId=301019, objectId=aafd3010194a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aafd3010194a, replyNumber=0, likeNumber=77, createdTime=2022-09-07, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aafd3010194a, moduleTitle=Fezolinetant治疗中度至重度血管舒缩症状，III期研究未达到主要终点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aafd3010194a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037426, encodeId=60a6203e42698, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=拜耳启动Elinzanetant III期临床研发项目OASIS，用于治疗更年期血管舒缩症状, objectType=article, longId=214643, objectId=e3b121464360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3b121464360, replyNumber=0, likeNumber=84, createdTime=2021-11-04, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3b121464360, moduleTitle=拜耳启动Elinzanetant III期临床研发项目OASIS，用于治疗更年期血管舒缩症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e3b121464360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037424, encodeId=72a1203e424dd, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=JAHA：更年期血管舒缩症状与心血管疾病事件风险的关系, objectType=article, longId=206033, objectId=1e83206033c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e83206033c6, replyNumber=0, likeNumber=74, createdTime=2021-07-23, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e83206033c6, moduleTitle=JAHA：更年期血管舒缩症状与心血管疾病事件风险的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1e83206033c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037423, encodeId=72c1203e42394, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=Mithra宣布Donesta治疗更年期血管舒缩症状（VMS）的III期临床试验已取得积极结果, objectType=article, longId=204701, objectId=9ebf204e014c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ebf204e014c, replyNumber=0, likeNumber=61, createdTime=2021-08-23, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ebf204e014c, moduleTitle=Mithra宣布Donesta治疗更年期血管舒缩症状（VMS）的III期临床试验已取得积极结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9ebf204e014c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037425, encodeId=1e60203e425e4, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=解决更年期女性的烦恼！新药fezolinetant治疗女性血管舒缩症状（VMS）疗效良好, objectType=article, longId=207380, objectId=d25720e38027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d25720e38027, replyNumber=0, likeNumber=88, createdTime=2021-09-11, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d25720e38027, moduleTitle=解决更年期女性的烦恼！新药fezolinetant治疗女性血管舒缩症状（VMS）疗效良好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d25720e38027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037422, encodeId=b730203e42241, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=更年期女性血管舒缩症状（VMS）：选择性NK3R拮抗剂MLE-301进入临床试验, objectType=article, longId=201327, objectId=1f2c20132e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f2c20132e3c, replyNumber=0, likeNumber=67, createdTime=2021-06-21, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f2c20132e3c, moduleTitle=更年期女性血管舒缩症状（VMS）：选择性NK3R拮抗剂MLE-301进入临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1f2c20132e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037421, encodeId=f96a203e42100, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=J Thromb Haemost：绝经后妇女血管舒缩症状与静脉血栓形成的风险！, objectType=article, longId=131571, objectId=b5691315e149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5691315e149, replyNumber=0, likeNumber=75, createdTime=2018-10-13, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5691315e149, moduleTitle=J Thromb Haemost：绝经后妇女血管舒缩症状与静脉血栓形成的风险！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b5691315e149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037420, encodeId=eb86203e420e7, content=<a href='/topic/show?id=e9e289e771c' target=_blank style='color:#2F92EE;'>#血管舒缩症状#</a>, objectTitle=Stroke：女性更年期血管舒缩症状轨迹可以预测心血管疾病的发生的风险, objectType=article, longId=59278, objectId=24b5592e85e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24b5592e85e, replyNumber=0, likeNumber=82, createdTime=2016-01-09, rootId=0, userName=12498561m32(暂无昵称), userId=d81c2500028, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24b5592e85e, moduleTitle=Stroke：女性更年期血管舒缩症状轨迹可以预测心血管疾病的发生的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=24b5592e85e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血管舒缩症状

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#绝经期# #血管舒缩症状# #亚临床动脉粥样硬化性心血管疾病#

JAHA：绝经期血管舒缩症状与亚临床动脉粥样硬化性心血管疾病的关系

2024-08-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#血管舒缩症状# #elinzanetant#

elinzanetant 新药递交FDA上市申请，用于治疗与绝经相关的中度至重度血管舒缩症状

2024-08-02发表于上海

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

Fezolinetant治疗中度至重度血管舒缩症状，III期研究未达到主要终点

2022-09-07

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

拜耳启动Elinzanetant III期临床研发项目OASIS，用于治疗更年期血管舒缩症状

2021-11-04

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

JAHA：更年期血管舒缩症状与心血管疾病事件风险的关系

2021-07-23

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

Mithra宣布Donesta治疗更年期血管舒缩症状（VMS）的III期临床试验已取得积极结果

2021-08-23

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

解决更年期女性的烦恼！新药fezolinetant治疗女性血管舒缩症状（VMS）疗效良好

2021-09-11

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

更年期女性血管舒缩症状（VMS）：选择性NK3R拮抗剂MLE-301进入临床试验

2021-06-21

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

J Thromb Haemost：绝经后妇女血管舒缩症状与静脉血栓形成的风险！

2018-10-13

12498561m32(暂无昵称) (审核中...)

前往app查看评论内容

#血管舒缩症状#

Stroke：女性更年期血管舒缩症状轨迹可以预测心血管疾病的发生的风险

2016-01-09

科室
- - 订阅+
  - 更多科室
工具
服务